High mortality risk of prostate cancer patients in Asia and West Africa: A systematic review.

作者: JudeO Okoye

DOI: 10.4103/AJM.AJM_19_20

关键词:

摘要: Globally, prostate cancer (PCa) is the second most preponderant in men. It contributes to high mortality-to-incidence ratio reported West Africa and Asia largely due low screening. The mortality risk determined or predicted based on prevalence of high-risk aggressive PCa using a scoring grading system such as Gleason score (GS), grade (GG), prostate-specific antigen (PSA) level. In this review, peer-reviewed articles found databases Google Scholar, Scopus, Web Science, PubMed Central and, EMBASE were selected adherence clinical guidelines for classification PCa. Asia, result revealed that frequency was 42% 51.2% GS, 48.8% 25.3% GG pattern, 87.5% 44.3% PSA level >10 ng/mL, respectively. Data both when compared with developed countries. However, higher than Asia. Studies have shown PCas are associated germline mutations prevalent blacks Asians whites. Thus, testing patients GS ≥ 7, 3, density, volume, levels >4.0 ng/mL may identify those at developing lethal could reduce rates Africa.

参考文章(70)
IE Bassey, IA Ekanem, UG Ugare, PG Jibrin, Analysis of Gleason grade and scores in 90 Nigerian Africans with prostate cancer during the period 1994 to 2004 African Health Sciences. ,vol. 12, pp. 69- 73 ,(2012) , 10.4314/AHS.V12I1
Jonathan I. Epstein, Michael J. Zelefsky, Daniel D. Sjoberg, Joel B. Nelson, Lars Egevad, Cristina Magi-Galluzzi, Andrew J. Vickers, Anil V. Parwani, Victor E. Reuter, Samson W. Fine, James A. Eastham, Peter Wiklund, Misop Han, Chandana A. Reddy, Jay P. Ciezki, Tommy Nyberg, Eric A. Klein, A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score European Urology. ,vol. 69, pp. 428- 435 ,(2016) , 10.1016/J.EURURO.2015.06.046
D. Dawam, A.H. Rafindadi, G.D. Kalayi, Benign prostatic hyperplasia and prostate carcinoma in native Africans. BJUI. ,vol. 85, pp. 1074- 1077 ,(2000) , 10.1046/J.1464-410X.2000.00677.X
Yao Zhu, Cheng-Tao Han, Hai-Tao Chen, Fang Liu, Gui-Ming Zhang, Wei-Yi Yang, Jian-Feng Xu, Ding-Wei Ye, Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort. Oncotarget. ,vol. 6, pp. 22978- 22984 ,(2015) , 10.18632/ONCOTARGET.3938
Ann W. Hsing, Edward Yeboah, Richard Biritwum, Yao Tettey, Angelo M. De Marzo, Andrew Adjei, George J. Netto, Kai Yu, Yan Li, Anand P. Chokkalingam, Lisa W. Chu, David Chia, Alan Partin, Ian M. Thompson, Sabah M. Quraishi, Shelley Niwa, Robert Tarone, Robert N. Hoover, High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer Journal of Urology. ,vol. 192, pp. 730- 736 ,(2014) , 10.1016/J.JURO.2014.04.017
R Lakhtakia, R Bharadwaj, VK Kumar, P Mandal, SK Nema, Immunophenotypic Characterization of Benign and Malignant Prostatic Lesions Medical journal, Armed Forces India. ,vol. 63, pp. 243- 248 ,(2007) , 10.1016/S0377-1237(07)80145-6
Vishvas Garg, Ning Yan Gu, Matthew E Borrego, Dennis W Raisch, A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening. Expert Review of Pharmacoeconomics & Outcomes Research. ,vol. 13, pp. 327- 342 ,(2013) , 10.1586/ERP.13.26
John Graham, Mark Baker, Fergus Macbeth, Victoria Titshall, Diagnosis and treatment of prostate cancer: summary of NICE guidance BMJ. ,vol. 336, pp. 610- 612 ,(2008) , 10.1136/BMJ.39498.525706.AD